TuHURA Biosciences, Inc./NV 8-K

What Happened
On April 1, 2026, TuHURA Biosciences, Inc. (HURA) issued a press release reporting its financial results for the year ended December 31, 2025 and providing a corporate update. The press release is attached to the Form 8-K as Exhibit 99.1. The Form 8-K states that the information is being furnished (not filed) and was signed by Dan Dearborn, Chief Financial Officer.

Key Details

• Filing date: April 1, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Period covered: Financial results for the year ended December 31, 2025.
• Exhibit: Press release attached as Exhibit 99.1 to the Form 8-K.
• Legal note: Information is furnished, not filed, per the Form 8-K language; the report was signed by CFO Dan Dearborn.

Why It Matters
This 8-K tells investors that TuHURA has publicly released its full-year 2025 financial results and a corporate update; those details (revenue, earnings/loss, cash position, guidance) appear in the attached press release. Because the Form 8-K furnishes rather than files the release, investors should review Exhibit 99.1 and watch for subsequent SEC filings (e.g., 10-K) for audited figures and additional disclosures that could affect valuation or near-term trading decisions.